##Amirabadi, F., Asadi, M., & Tabrizi, A. (2016). The effect of endurance training and use of cinnamon supplement on antioxidant index and lipid peroxidation as additional care in middle-aged female diabetic type II patients. Journal of Diabetes Nursing, 4(3), 48-59. ##Association, A. D. (2014). Diagnosis and classification of diabetes mellitus. Diabetes care, 37(Supplement 1), S81-S90. ##Bentsen, M. A., Rausch, D. M., Mirzadeh, Z., Muta, K., Scarlett, J. M., Brown, J. M., . . . Alonge, K. M. (2020). Transcriptomic analysis links diverse hypothalamic cell types to fibroblast growth factor 1-induced sustained diabetes remission. Nature communications, 11(1), 1-16. ##Christ-Roberts, C. Y., Pratipanawatr, T., Pratipanawatr, W., Berria, R., Belfort, R., Kashyap, S., & Mandarino, L. J. (2004). Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects. Metabolism, 53(9), 1233-1242. ## Fan, L., Ding, L., Lan, J., Niu, J., He, Y., & Song, L. (2019). Fibroblast growth factor-1 improves insulin resistance via repression of JNK-mediated inflammation. Frontiers in pharmacology, 10, 1478. ## Flores-Opazo, M., McGee, S. L., & Hargreaves, M. (2020). Exercise and GLUT4. Exercise and sport sciences reviews, 48(3), 110-118. ##Gasser, E., Moutos, C. P., Downes, M., & Evans, R. M. (2017). FGF1—a new weapon to control type 2 diabetes mellitus. Nature Reviews Endocrinology, 13(10), 599-609. ## Gholami, M., Eftekhari, E., Zafari, A., & Solatzadeh, O. (2017). Effect of eight weeks low and moderate intensity aerobic training on levels of HbA1C, some hematological parameters and percent body fat in overweight and obese men with type 2 diabetes. Metabolism and Exercise, 7(2), 155-168. ##Handschin, C., & Spiegelman, B. M. (2008). The role of exercise and PGC1α in inflammation and chronic disease. Nature, 454(7203), 463-469. ##Irfannuddin, I., Santoso, B., Zein, R. H., & Naufal, A. F. (2019). The effect of aerobic exercise and caloric restriction on mice’s brain tissue PGC-1α levels and their memory abilities. Journal of Physics: Conference Series, ## Jeon, J. Y., Ko, S.-H., Kwon, H.-S., Kim, N. H., Kim, J. H., Kim, C. S., . . . Choi, S. H. (2013). Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c. Diabetes & metabolism journal, 37(5), 349-357. ##Jonker, J. W., Suh, J. M., Atkins, A. R., Ahmadian, M., Li, P., Whyte, J., . . . Phillips, C. T. (2012). A PPARγ–FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature, 485(7398), 391-394. ##Kang, S., Woo, J. H., Shin, K. O., Kim, D., Lee, H.-J., Kim, Y. J., & Yeo, N. H. (2009). Circuit resistance exercise improves glycemic control and adipokines in females with type 2 diabetes mellitus. Journal of sports science & medicine, 8(4), 682. ##Karami, M., & Banitalebi, E. (2017). The comparision of effect of 8 weeks of intense interval training and combined strength-endurance training on fibroblast growth factor-21 (FGF-21) levels in women with type 2 diabetes. Journal of Nursing Education, 6(3), 37-46. ## Keihanian, A., Arazi, H., & Kargarfard, M. (2019). Effects of aerobic versus resistance training on serum fetuin-A, fetuin-B, and fibroblast growth factor-21 levels in male diabetic patients. Physiology international, 106(1), 70-80. ##Kim, H.-J., Li, Q., Song, W.-J., Yang, H.-M., Kim, S.-Y., Park, S.-C., . . . Youn, H.-Y. (2018). Fibroblast growth factor-1 as a mediator of paracrine effects of canine adipose tissue-derived mesenchymal stem cells on in vitro-induced insulin resistance models. BMC veterinary research, 14(1), 1-10. ##Koval, J. A., DeFronzo, R. A., O’Doherty, R. M., Printz, R., Ardehali, H., Granner, D. K., & Mandarino, L. J. (1998). Regulation of hexokinase II activity and expression in human muscle by moderate exercise. American Journal of Physiology-Endocrinology And Metabolism, 274(2), E304-E308. ## Li, X. (2019). The FGF metabolic axis. Frontiers of medicine, 13(5), 511-530. ##Liang, G., Song, L., Chen, Z., Qian, Y., Xie, J., Zhao, L., . . . Li, X. (2018). Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism. Kidney international, 93(1), 95-109. ##Marton, O., Koltai, E., Takeda, M., Koch, L. G., Britton, S. L., Davies, K. J., . . . Radak, Z. (2015). Mitochondrial biogenesis-associated factors underlie the magnitude of response to aerobic endurance training in rats. Pflügers Archiv-European Journal of Physiology, 467(4), 779-788. ##Miller, D. L., Ortega, S., Bashayan, O., Basch, R., & Basilico, C. (2000). Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Molecular and cellular biology, 20(6), 2260-2268. ##Mohammadi, M., Olsen, S. K., & Ibrahimi, O. A. (2005). Structural basis for fibroblast growth factor receptor activation. Cytokine & growth factor reviews, 16(2), 107-137. ##Morville, T., Sahl, R. E., Trammell, S. A., Svenningsen, J. S., Gillum, M. P., Helge, J. W., & Clemmensen, C. (2018). Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans. JCI insight, 3(15). ##Ozougwu, J., Obimba, K., Belonwu, C., & Unakalamba, C. (2013). The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. Journal of physiology and pathophysiology, 4(4), 46-57. ## Powers, C., McLeskey, S., & Wellstein, A. (2000). Fibroblast growth factors, their receptors and signaling. Endocrine-related cancer, 7(3), 165-197. ##Raju, R., Palapetta, S. M., Sandhya, V. K., Sahu, A., Alipoor, A., Balakrishnan, L., . . . Geetha, N. (2014). A network map of FGF-1/FGFR signaling system. Journal of signal transduction, 2014. ##Rao, S., Sundaram, S., & Duvuru, P. (2011). Carcinoma ex pleomorphic adenoma: a rare sight on cytology. Sri Ramachandra J Med, 4, 45-47. ##Richter, E. A., & Hargreaves, M. (2013). Exercise, GLUT4, and skeletal muscle glucose uptake. Physiological reviews. ##Saydi, A., & Sheikholeslami-Vatani, D. (2019). The Effect of Resistance Training with High and Moderate Intensities on Lipid Profile, Glycemic Index and FGF21 in Type 2 Diabetic Patients. Sport Physiology & Management Investigations, 11(3), 89-103. ##Scarlett, J. M., Muta, K., Brown, J. M., Rojas, J. M., Matsen, M. E., Acharya, N. K., . . . Høeg-Jensen, T. (2019). Peripheral mechanisms mediating the sustained antidiabetic action of FGF1 in the brain. Diabetes, 68(3), 654-664. ##Scarlett, J. M., Rojas, J. M., Matsen, M. E., Kaiyala, K. J., Stefanovski, D., Bergman, R. N., . . . Wasserman, D. H. (2016). Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents. Nature medicine, 22(7), 800-806. ## Steiner, J. L., Murphy, E. A., McClellan, J. L., Carmichael, M. D., & Davis, J. M. (2011). Exercise training increases mitochondrial biogenesis in the brain. Journal of Applied Physiology, 111(4), 1066-1071. ## Struik, D., Dommerholt, M. B., & Jonker, J. W. (2019). Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application. Current opinion in lipidology, 30(3), 235. ##Suh, J. M., Jonker, J. W., Ahmadian, M., Goetz, R., Lackey, D., Osborn, O., . . . van Dijk, T. H. (2014). Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature, 513(7518), 436-439. ## Tennant, K. G., Lindsley, S. R., Kirigiti, M. A., True, C., & Kievit, P. (2019). Central and peripheral administration of fibroblast growth factor 1 improves pancreatic islet insulin secretion in diabetic mouse models. Diabetes, 68(7), 1462-1472. ## Uth, N., Sørensen, H., Overgaard, K., & Pedersen, P. K. (2004). Estimation of V̇ O 2max from the ratio between HR max and HR rest–the Heart Rate Ratio Method. European Journal of Applied Physiology, 91(1), 111-115. ##Wang, S., Yang, Q., Yu, S., Pan, R., Jiang, D., Liu, Y., . . . Xue, H. (2016). Fibroblast growth factor 1 levels are elevated in newly diagnosed type 2 diabetes compared to normal glucose tolerance controls. Endocrine journal, 63(4), 359-365. ##Wu, Y., Li, Y., Jiang, T., Yuan, Y., Li, R., Xu, Z., . . . Xie, L. (2018). Reduction of cellular stress is essential for Fibroblast growth factor 1 treatment for diabetic nephropathy. Journal of cellular and molecular medicine, 22(12), 6294-6303. ##Wu, Y., Wu, C., Ye, L., Wang, B., Yuan, Y., Liu, Y., . . . Jiang, T. (2020). Exogenous fibroblast growth factor 1 ameliorates diabetes-induced cognitive decline via coordinately regulating PI3K/AKT signaling and PERK signaling. Cell Communication and Signaling, 18, 1-15. ##Xiong, Y., Chen, Y., Liu, Y., & Zhang, B. (2020). Moderate-Intensity Continuous Training Improves FGF21 and KLB Expression in Obese Mice. Biochemistry (Moscow), 85(8), 938-946. ##Zakrzewska, M., Marcinkowska, E., & Wiedlocha, A. (2008). FGF-1: from biology through engineering to potential medical applications. Critical reviews in clinical laboratory sciences, 45(1), 91-135. ##
)